Faculty Directory

Laura Faden Garabedian

Assistant Professor

Dr. Garabedian is an Assistant Professor in the Department of Population Medicine (DPM) in the Division of Health Policy and Insurance Research (HPI). Her research is focused on the robust evaluation of global and domestic health insurance reforms, health care delivery system reforms and pharmaceutical policies using quasi-experimental research methods and routinely collected health insurance claims datasets. She is also interested in the evaluation and development of analytic methods for health policy research, with a particular focus on observational data methods.

Dr. Garabedian has a strong commitment to teaching. Within the department, she is Director of Teaching Programs and Co-Director of the Harvard Medical School Fellowship in Health Policy and Insurance Research. At Harvard Medical School, Dr. Garabedian serves as Co-Director of the Clinical Epidemiology and Population Health longitudinal curriculum and Co-Director of Essentials of the Profession I, a required first-year course that covers health policy, medical ethics, social medicine and clinical epidemiology and population health. She also teaches and mentors students in the Harvard PhD Program in Health Policy.

Dr. Garabedian received her PhD in Health Policy from Harvard University, with a specialization in evaluative science and statistics. She was a pre-doctoral Pharmaceutical Policy Research Fellow and a post-doctoral Pyle Fellow at DPM. Prior to Harvard, Dr. Garabedian worked as a research analyst at the Tufts Center for the Study of Drug Development. She has an MPH from Tufts and a BA from Boston University.

Selected Publications:

  • Garabedian LF, Ross-Degnan D, Soumerai S, Choudhry N, Brown JS. Impact of Massachusetts Health Reform on Enrollment Length and Health Care Utilization in the Unsubsidized Individual Market. Health Services Research. 2017; 52(3): 1118-1137

  • Garabedian LF, Chu P, Toh S, Zaslavsky AM, Soumerai SB. Potential Bias of Instrumental Variable Analyses for Observational Comparative Effectiveness Research. Annals of Internal Medicine. 2014; 161(2):131-138.

  • Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012; 2(6).  Available at: http://bmjopen.bmj.com/content/2/6/e001686.full



In the Media